Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: condition (1000), situation (241), incident (87), fact (114), event (609), accident (116)

Tivozanib

Description: Chemotherapy Protocol RENAL CELL Regimen TIVOZANIB • Renal Cell - Tivozanib Indication • Patients with a confirmed histological diagnosis of renal cell carcinoma with
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Renal-cell/Tivozanib.pdf

Manslaughter by doctors

Description: Auto Generated Title On these pages I discuss the clinical law on which our nursing and medical staff rely when caring
Url: /HealthProfessionals/Clinical-law-updates/Manslaughter-by-doctors.aspx

UHS AR 23-24 Final

Description: 2023/24 Incorporating the quality account University Hospital Southampton NHS Foundation Trust Annual Report and Accounts 2023/24 Presented to Parliament
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Annual-reports-and-quality-accounts/UHS-AR-23-24-Final.pdf

UHS AR 21-22 Quality Account

Description: QUALITY ACCOUNT 2021/22 Part 1: QStaUteAmeLnItToYn qAuaClitCy fOroUm NtheTchief executive 2021/22 1.1 Chief executive’s statement and welcome
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Annual-reports-and-quality-accounts/UHS-AR-21-22-Quality-Account.pdf

Lenvatinib(60kg or greater)

Description: Chemotherapy Protocol HEPATOCELLULAR CANCER LENVATINIB (60kg or greater) Regimen • Hepatocellular – Lenvatinib Indication • Lenvatinib is indicated where either; - the patient has a
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Hepatobiliary/Lenvatinib-60kg-or-greater-Ver1.pdf

Lenvatinib(59kg or less)

Description: Chemotherapy Protocol HEPATOCELLULAR CANCER LENVATINIB (59kg or less) Regimen • Hepatocellular – Lenvatinib Indication • Lenvatinib is indicated where either; - the patient has a
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Hepatobiliary/Lenvatinib-59kg-or-less-.pdf

Vulnerable with capacity

Description: Are there situations where a capacitous patient is nonetheless vulnerable to adverse decision making?
Url: /HealthProfessionals/Clinical-law-updates/Vulnerable-with-capacity.aspx

NIHR BRC Education and Training Fund 3rd call Information Sheet

Description: For Biomedical Research Centre (BRC) in association with Southampton Academy of Research (SoAR) Education, Training & Career Development Fund Information on th
Url: /Media/Southampton-Clinical-Research/SoAR/NIHR-BRC-Education-and-Training-Fund-3rd-call-Information-Sheet.docx

Apply to court

Description: In clinical practice, decisions relating to adults who lack capacity are ubiquitous, both to relation to the need for new treatment
Url: /HealthProfessionals/Clinical-law-updates/Apply-to-court.aspx

Be informed; then disclose

Description: Be informed; then disclose
Url: /HealthProfessionals/Clinical-law-updates/Be-informed-then-disclose.aspx

41 to 50 of 749

Previous … 3 4 5 6 7 … Next